证券代码：603607 证券简称：京华激光 公告编号：2025-027 浙江京华激光科技股份有限公司 冯一平女士、谢高翔先生因个人资金需求，自本公告披露之日起 15 个交易 日后 3 个月内（窗口期等不减持股份），拟通过集中竞价、大宗交易方式，减持 不超过其各自所持公司股份总数的 25%，合计将减持不超过 1,434,200 股的本公 司股份，约占公司总股本的 0.8034%。减持价格根据减持时的市场价格确定。若 减持期间公司有送股、资本公积转增股本等变动事项，应对上述减持数量做相应 调整。 一、减持主体的基本情况 | 冯一平 | | | | | 股东名称 | | --- | --- | --- | --- | --- | --- | | 控股股东、实控人及一致行动人 | □是 | √否 | | | | | 直接持股 5%以上股东 | □是 √否 | | | | 股东身份 | | 董事、监事和高级管理人员 | √是 □否 | | | | | | 其他：不适用 | | | | | | | 4,161,511股 | | | | | 持股数量 | | 2.3312% | | | | | 持股比例 | | IPO 前 ...

Summary of Key Points Core Viewpoint - On September 1, Guizhou Moutai disclosed an increase in shareholding, while 18 A-share listed companies announced share reductions by their shareholders [1][3]. Group 1: Guizhou Moutai - The controlling shareholder of Guizhou Moutai increased their holdings by 67,800 shares [3]. Group 2: Share Reduction Announcements - Jinli Technology: Shareholder Wang Gangjuan plans to reduce holdings by up to 978,200 shares [3]. - New Agricultural Shares: Shareholder Dai Jingu intends to reduce holdings by up to 1,050,000 shares [3]. - Weima Agricultural Machinery: Chongqing Baoxia plans to reduce holdings by up to 0.98% of the company [3]. - Jiaman Apparel: Shareholder Shenzhen Jiaqiao plans to reduce holdings by up to 0.28238% [3]. - Fangyuan Shares: Shareholder Wuzhong Yuanding plans to reduce holdings by up to 3% [3]. - Kesi Technology: Liang Hongjian intends to reduce holdings by up to 3% [3]. - Shengtai Group: Itochu Asia plans to reduce holdings by up to 3% [3]. - Tenglong Shares: Jiang Yilin reduced holdings by 250,000 shares on August 28 [3]. - Haojiang Intelligent: Shareholder Nanjing Fuhua plans to reduce holdings by up to 1,500,000 shares [3]. - Dekeli: Shareholders holding over 5% plan to reduce holdings by up to 2.9957% [3]. - Yaxiang Integration: Shareholder plans to reduce holdings by up to 0.54% [3]. - Zhonglun New Materials: Shareholder plans to reduce holdings by up to 1% of total share capital [3]. - Juhualong: Shareholder Dongtai Juhua Ying plans to reduce holdings by up to 1% [3]. - Yidamo: Shareholder Qingyuan China plans to reduce holdings by up to 1% [3]. - Zhongtie Dingye: Shareholder Zhongyuan Equity commits not to reduce holdings within 36 months [3]. - Jinghua Laser: Directors and senior management plan to reduce holdings by up to 1,434,200 shares [3]. - Haotaitai: Shareholder Hou Pengde plans to reduce holdings by up to 0.8698% [3]. - Longqi Technology: Shareholder Suzhou Shunwei plans to reduce holdings by up to 4.09% [3].

Group 1: BYD Performance - BYD's August sales of new energy vehicles reached 373,600 units, nearly unchanged from 373,100 units in the same month last year [1] - Cumulative sales from January to August totaled 2.864 million units, representing a year-on-year growth of 23% [1] - BYD plans to export a total of 80,813 new energy vehicles by August 2025 [1] Group 2: Kweichow Moutai Shareholding - Kweichow Moutai's controlling shareholder, Moutai Group, increased its stake by 67,821 shares on September 1, 2025, accounting for 0.0054% of the total share capital [2] - The increase amounted to 100 million yuan and is part of a larger plan to buy back between 3 billion and 3.3 billion yuan worth of shares from September 1, 2025, to February 28, 2026 [2] Group 3: Chengdu Huamei Chip Development - Chengdu Huamei announced the successful launch of a 4-channel, 12-bit, 40G high-speed, high-precision RF direct sampling ADC chip [3] - The chip improves upon existing multi-channel high-speed ADCs, achieving international leading standards and filling a gap in similar products [3] - The company has received intention orders after sending samples to several clients [3] Group 4: Industrial Fulian Share Buyback - Industrial Fulian has repurchased a total of 7.6974 million shares, representing 0.04% of its total share capital, as of August 31, 2025 [6] - The highest repurchase price was 19.84 yuan per share, while the lowest was 18.40 yuan per share, with a total expenditure of 147 million yuan [6] Group 5: Innovative Drug Approval by Hengrui Medicine - Hengrui Medicine received conditional approval from the National Medical Products Administration for its innovative drug, SHR2554 tablets, aimed at adult patients with relapsed or refractory peripheral T-cell lymphoma [7] - This drug is noted as China's first independently developed EZH2 inhibitor [7] Group 6: Yonghui Supermarket Fundraising Adjustment - Yonghui Supermarket announced adjustments to its plan for issuing A-shares to specific investors, reducing the total fundraising amount from a maximum of 3.992 billion yuan to 3.114 billion yuan [8] - The adjustments primarily affect the funding amounts for store upgrades and working capital or bank loan repayments [8] Group 7: Automotive Sales Performance - SAIC Motor's vehicle sales in August reached 363,400 units, reflecting a year-on-year increase of 41.04% [9] - Great Wall Motors reported August sales of 115,600 units, marking a year-on-year growth of 22.33% [12] - Dong'an Power's engine sales in August increased by 3.44% year-on-year [12]

人民财讯9月1日电，京华激光（603607）9月1日晚间公告，公司董事兼副总经理、财务总监冯一平，董 事兼副总经理谢高翔，因个人资金需求，自15个交易日后3个月内，拟通过集中竞价、大宗交易方式， 合计将减持公司股份不超过143.42万股(约占公司总股本的0.8%)。 ...

格隆汇9月1日丨京华激光(603607.SH)公布，冯一平女士、谢高翔先生因个人资金需求，自本公告披露 之日起15个交易日后3个月内（窗口期等不减持股份），拟通过集中竞价、大宗交易方式，减持不超过 其各自所持公司股份总数的25%，合计将减持不超过1,434,200股的本公司股份，约占公司总股本的 0.8034%。减持价格根据减持时的市场价格确定。 ...

浙江京华激光科技股份有限公司 证券代码：603607 证券简称：京华激光 公告编号：2025-027 董事、高级管理人员减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 董事、高级管理人员持股的基本情况 截至本公告披露日，浙江京华激光科技股份有限公司（以下简称"公司"） 董事兼副总经理、财务总监冯一平女士持有公司股份 4,161,511 股，占公司总股 本的 2.3312%；董事兼副总经理谢高翔先生持有公司股份 1,737,151 股，占公司 总股本的 0.9731%。股份来源为公司首次公开发行前持有的股份及上市后以资本 公积转增股本方式取得的股份。 减持计划的主要内容 冯一平女士、谢高翔先生因个人资金需求，自本公告披露之日起 15 个交易 日后 3 个月内（窗口期等不减持股份），拟通过集中竞价、大宗交易方式，减持 不超过其各自所持公司股份总数的 25%，合计将减持不超过 1,434,200 股的本公 司股份，约占公司总股本的 0.8034%。减持价格根据减持时的市场价格确定。若 减持 ...

证券之星价投圈财报分析工具显示：业务评价：公司去年的ROIC为7.54%，资本回报率一般。去年的净 利率为11.57%，算上全部成本后，公司产品或服务的附加值一般。从历史年报数据统计来看，公司上 市以来中位数ROIC为12.32%，投资回报也较好，其中最惨年份2023年的ROIC为7.11%，投资回报一 般。公司历史上的财报较为好看(注：公司上市时间不满10年，上市时间越长财务均分参考意义越 大。)。偿债能力：公司现金资产非常健康。商业模式：公司业绩主要依靠研发驱动。需要仔细研究这 类驱动力背后的实际情况。 据证券之星公开数据整理，近期京华激光(603607)发布2025年中报。截至本报告期末，公司营业总收入 4.54亿元，同比上升19.61%，归母净利润4757.92万元，同比上升15.43%。按单季度数据看，第二季度 营业总收入2.15亿元，同比上升12.3%，第二季度归母净利润2217.17万元，同比上升20.16%。本报告期 京华激光公司应收账款体量较大，当期应收账款占最新年报归母净利润比达162.05%。 本次财报公布的各项数据指标表现一般。其中，毛利率28.81%，同比增4.33%，净利率10.5 ...

2025年8月28日，京华激光(603607.SH)发布2025年中报。 公司营业总收入为4.54亿元，较去年同报告期营业总收入增加7443.65万元，实现2年连续上涨，同比较 去年同期上涨19.61%。归母净利润为4757.92万元，在已披露的同业公司中排名第14，较去年同报告期 归母净利润增加636.18万元，实现2年连续上涨，同比较去年同期上涨15.43%。经营活动现金净流入为 1447.68万元。 公司最新资产负债率为28.95%，在已披露的同业公司中排名第10。 公司最新毛利率为28.81%，在已披露的同业公司中排名第4，较上季度毛利率增加0.92个百分点，较去 年同期毛利率增加1.20个百分点。最新ROE为4.83%，在已披露的同业公司中排名第8，较去年同期ROE 增加0.70个百分点。 公司摊薄每股收益为0.27元，在已披露的同业公司中排名第6，较去年同报告期摊薄每股收益增加0.04 元，实现2年连续上涨，同比较去年同期上涨17.39%。 公司最新总资产周转率为0.29次，较去年同期总资产周转率增加0.03次，实现2年连续上涨，同比较去年 同期上涨12.56%。最新存货周转率为2.32次，较去年 ...

Core Insights - The article highlights the positive performance of major Japanese companies in the trading card game (TCG) sector for the first half of 2025, with notable sales growth across various brands [1] - In China, there is a surge in demand for card products, particularly following the release of the domestic film "Nezha: Birth of the Demon Child," which significantly boosted related card sales [1][2] Company Performance - Bandai's One Piece TCG released 10 new card packs, contributing to strong sales [1] - Bushiroad's TCG business saw a year-on-year sales increase of 34.42% [1] - Jinghua Laser reported a 61.98% year-on-year revenue growth in its cultural business, driven by the popularity of the "Nezha" card products [1][2] - Yaoji Technology's subsidiary "Katao" achieved approximately 105 million yuan in revenue, a 33% increase year-on-year, with a net profit of about 12 million yuan, up 39% [4] - Huali Technology's revenue from anime IP derivative products reached approximately 166 million yuan, a 14.51% increase, although its gross margin declined from 44% to 39% [7][9] Market Trends - The article notes a shift in the market, with three-dimensional IP card products experiencing explosive growth, while two-dimensional anime IP collectible cards are entering a period of adjustment [15] - The Ultraman franchise is facing challenges, with a 7.4% decline in toy revenue and a significant drop in other merchandise categories, despite a surge in TCG sales due to the launch of the "ULTRAMAN CARDGAME" [15][16] - The article emphasizes the need for new hit products in the two-dimensional IP collectible card market to revitalize interest, as no new titles have matched the success of "Nezha" or previous hits like "My Little Pony" and "Ultraman" [15][18]

Group 1 - The company announced the nomination of Mr. Sun Jiashui as a candidate for the non-independent director of the fourth board of directors [1]